文献速递新发突发、热带与寄生虫病

他非诺喹能否革新田鼠巴贝虫感染的治疗?

Could the Drug Tafenoquine Revolutionize Treatment of Babesia microti Infection?
PubMed 文献 · J Infect Dis · 2019-01-01

该研究在重度联合免疫缺陷(SCID)小鼠模型中评估他非诺喹(TQ)对田鼠巴贝虫感染的治疗效果。小鼠腹腔接种1.1–1.5×10^8个感染红细胞,于感染后第3或4天(虫血症常超过10%)口服TQ或溶媒。单剂TQ完全清除可检测寄生虫,4天内虫血症下降超过90%,未达到寄生虫学治愈,但未见耐药证据。

要点

  • 单剂口服TQ在SCID小鼠中完全清除可检测的田鼠巴贝虫。
  • 用药4天内虫血症下降超过90%,清除前可见寄生虫明显形态学改变。
  • 未达寄生虫学治愈且未见耐药,提示TQ可能成为治疗巴贝虫病的候选药物。

核心结论

  • 本研究提示TQ可能对治疗田鼠巴贝虫感染高度有用,若进一步动物研究证实可可靠实现虫血症显著下降且血药峰值在人类可耐受范围内,应考虑开展患者临床试验。

研究设计与样本

  • SCID小鼠腹腔注射1.1–1.5×10^8个田鼠巴贝虫感染红细胞,感染后第3或4天虫血症常超过10%时,口服灌胃给予TQ或单用溶媒对照。

主要发现

  • 单剂TQ完全清除可检测寄生虫,仅4天内虫血症水平下降超过90%。
  • 寄生虫被清除前观察到明显的表型改变,未达到寄生虫学治愈,但无耐药发生的证据。

临床怎么用

  • 目前仅为小鼠模型结果,尚不能直接用于临床用药决策,需进一步动物研究及患者临床试验验证。

局限性

  • 研究采用SCID小鼠模型,样本量与具体剂量原文未报告,结果外推至患者需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tafenoquine (TQ) was recently approved by the US Food and Drug Administration for prophylaxis of malaria and, in addition, for eradication of the hepatic phase of the relevant Plasmodium species. In this study, we evaluated the efficacy of TQ for treatment of Babesia microti infection in mice with severe combined immunodeficiency (SCID). METHODS: SCID mice were infected with 1.1-1.5 × 108 B. microti-infected red blood cells by intraperitoneal injection. On day 3 or 4 postinfection, when parasitemia levels typically exceeded 10%, mice were treated with TQ vs vehicle alone, both administered by oral gavage. RESULTS: A single dose of TQ completely eliminated detectable parasites, with a >90% reduction in the level of parasitemia within just 4 days. Before elimination, a conspicuous phenotypic change in the parasite was observed. Although parasitologic cure was not achieved, there was no evidence for the development of drug resistance. CONCLUSIONS: This study suggests that TQ may be a highly useful drug to treat B. microti infection in patients. If further animal studies establish that a marked reduction in B. microti parasitemia can be reliably achieved with peak blood levels of TQ known to be well tolerated in humans, a clinical trial in patients should be considered.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Mordue DG, Wormser GP. Could the Drug Tafenoquine Revolutionize Treatment of Babesia microti Infection? J Infect Dis. 2019. PMID: 31099380. doi:10.1093/infdis/jiz119

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。